273 related articles for article (PubMed ID: 34054796)
1. Immunologic Rejection of Transplanted Retinal Pigmented Epithelium: Mechanisms and Strategies for Prevention.
Petrash CC; Palestine AG; Canto-Soler MV
Front Immunol; 2021; 12():621007. PubMed ID: 34054796
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cell-based therapy for age-related macular degeneration.
Bracha P; Moore NA; Ciulla TA
Expert Opin Biol Ther; 2017 Sep; 17(9):1113-1126. PubMed ID: 28664762
[TBL] [Abstract][Full Text] [Related]
3. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
[TBL] [Abstract][Full Text] [Related]
4. [Preclinical Study of Human Induced Pluripotent Stem Cell-derived Retinal Pigment Epithelium Cell Sheets Transplantation].
Kamao H
Nippon Ganka Gakkai Zasshi; 2016 Nov; 120(11):754-63. PubMed ID: 30074740
[TBL] [Abstract][Full Text] [Related]
5. Concise Review: Update on Retinal Pigment Epithelium Transplantation for Age-Related Macular Degeneration.
Zarbin M; Sugino I; Townes-Anderson E
Stem Cells Transl Med; 2019 May; 8(5):466-477. PubMed ID: 30748126
[TBL] [Abstract][Full Text] [Related]
6. Advancing a Stem Cell Therapy for Age-Related Macular Degeneration.
O'Neill HC; Limnios IJ; Barnett NL
Curr Stem Cell Res Ther; 2020; 15(2):89-97. PubMed ID: 31854278
[TBL] [Abstract][Full Text] [Related]
7. Cell-Based Therapy for Degenerative Retinal Disease.
Zarbin M
Trends Mol Med; 2016 Feb; 22(2):115-134. PubMed ID: 26791247
[TBL] [Abstract][Full Text] [Related]
8. Generation of Transplantable Retinal Pigmented Epithelial (RPE) Cells for Treatment of Age-Related Macular Degeneration (AMD).
Surendran H; Rathod RJ; Pal R
Methods Mol Biol; 2019; 2045():283-298. PubMed ID: 29896658
[TBL] [Abstract][Full Text] [Related]
9. Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration.
Kanemura H; Go MJ; Shikamura M; Nishishita N; Sakai N; Kamao H; Mandai M; Morinaga C; Takahashi M; Kawamata S
PLoS One; 2014; 9(1):e85336. PubMed ID: 24454843
[TBL] [Abstract][Full Text] [Related]
10. Retinal Pigment Epithelium Replacement Therapy for Age-Related Macular Degeneration: Are We There Yet?
Sharma R; Bose D; Maminishkis A; Bharti K
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():553-572. PubMed ID: 31914900
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
[TBL] [Abstract][Full Text] [Related]
12. Detection of Retinal Pigment Epithelium-Specific Antibody in iPSC-Derived Retinal Pigment Epithelium Transplantation Models.
Sugita S; Makabe K; Fujii S; Iwasaki Y; Kamao H; Shiina T; Ogasawara K; Takahashi M
Stem Cell Reports; 2017 Nov; 9(5):1501-1515. PubMed ID: 29103970
[TBL] [Abstract][Full Text] [Related]
13. Stem cell-derived retinal pigment epithelium transplantation for treatment of retinal disease.
Nommiste B; Fynes K; Tovell VE; Ramsden C; da Cruz L; Coffey P
Prog Brain Res; 2017; 231():225-244. PubMed ID: 28554398
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Transplant Effects of iPSC-RPE Monolayer in Immunodeficient RCS Rats.
Rajendran Nair DS; Zhu D; Sharma R; Martinez Camarillo JC; Bharti K; Hinton DR; Humayun MS; Thomas BB
Cells; 2021 Oct; 10(11):. PubMed ID: 34831174
[TBL] [Abstract][Full Text] [Related]
15. Cell-Based Therapies for Age-Related Macular Degeneration.
Khateb S; Jha S; Bharti K; Banin E
Adv Exp Med Biol; 2021; 1256():265-293. PubMed ID: 33848006
[TBL] [Abstract][Full Text] [Related]
16. Immunological aspects of RPE cell transplantation.
Sugita S; Mandai M; Kamao H; Takahashi M
Prog Retin Eye Res; 2021 Sep; 84():100950. PubMed ID: 33482342
[TBL] [Abstract][Full Text] [Related]
17. Protective Effects of Human iPS-Derived Retinal Pigmented Epithelial Cells in Comparison with Human Mesenchymal Stromal Cells and Human Neural Stem Cells on the Degenerating Retina in rd1 mice.
Sun J; Mandai M; Kamao H; Hashiguchi T; Shikamura M; Kawamata S; Sugita S; Takahashi M
Stem Cells; 2015 May; 33(5):1543-53. PubMed ID: 25728228
[TBL] [Abstract][Full Text] [Related]
18. What's old is new again: Autologous stem cell transplant for AMD.
Byrne LC
Sci Transl Med; 2017 Apr; 9(387):. PubMed ID: 28446683
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa.
Li Y; Tsai YT; Hsu CW; Erol D; Yang J; Wu WH; Davis RJ; Egli D; Tsang SH
Mol Med; 2012 Dec; 18(1):1312-9. PubMed ID: 22895806
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of RPE cells from integration-free iPS cells and their cell biological characterization.
Hazim RA; Karumbayaram S; Jiang M; Dimashkie A; Lopes VS; Li D; Burgess BL; Vijayaraj P; Alva-Ornelas JA; Zack JA; Kohn DB; Gomperts BN; Pyle AD; Lowry WE; Williams DS
Stem Cell Res Ther; 2017 Oct; 8(1):217. PubMed ID: 28969679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
